Kaiser Permanente Colorado Institute for Health Research
Denver, Colorado, 80231, United States
NCT Number: NCT03516682
This study will assess the impact of automated reminders for the 6 month and 12 month vaccine visits to increase vaccination in parents experiencing logistic barriers to vaccination.
Looking for future studies?
Notify Me1 month–11 month
All sexes
Interventional
Not applicable
Denver, Colorado, 80231, United States
Parents of children less than 11 months of age will be identified as delayed or missing vaccinations due to logistic barriers in the Kaiser Permanente Colorado population. Parents identified will be randomized to the intervention arm or the usual care arm. Those in the intervention arm will receive automated reminders for the 6 month and 12 month vaccine visits. Reminders will include scheduling information as well as access to a website with vaccine and scheduling information. They will also have an opportunity to provide preferences in how they receive the automated reminders (text, phone or email). There will be 2 reminders before the 6 and 12 month visits and 2 after the 6 and 12 month visits. Parents will be excluded from receiving reminders if they have received vaccines within the time frame when they are eligible to receive another vaccine or have a well child visit scheduled.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Automated reminders for the 6 month and 12 month vaccine visits for parents experiencing logistic barriers to vaccination.
Other names: REDIVAC-Logistic Barriers
Time frame: up to a year of follow up
Vaccination records from the participants electronic health record will be used to measure vaccines received. Vaccines received is a dichotomous variable indicating if any vaccines were received while enrolled in the study
Time frame: up to a year of follow up
Vaccination records from the participants electronic health record will be used to measure vaccine dose. Vaccine dose is a measure of the vaccine doses that the child could have received while enrolled in the study, the number of vaccine doses received
Kaiser Permanente
Other
The REDIVAC Study-Reducing Delay in Vaccination of Children Study
Acronym: REDIVAC-LB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04540484
COVID-19, Communicable Disease
Park Ridge, Illinois, United States
View Trial DetailsNCT05307991
Bacterial Infections, Bacterial Infections and Mycoses
Lilongwe, Malawi
View Trial DetailsNCT04644484
Communicable Disease, Communicable Diseases
Kunming, China
View Trial DetailsNCT04367740
Asymptomatic Condition, Asymptomatic Diseases
Chapel Hill, North Carolina, United States
View Trial Details